Growing prevalence of infections and surge in demand for minimally invasive surgeries is expected to drive the United States biopsy devices market for the forecast period.
According to TechSci Research report, “United States Biopsy Devices Market By Type (Surgical Biopsy v/s Needle Biopsy) By Technique (Ultrasound-guided Biopsy, MRI-guided Biopsy, Stereotactic-guided Biopsy, Others) By Product (Needle-based Biopsy Instruments, Localization Wires, Procedure Trays, Others) By Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others) By End User (Hospitals & Clinics, Diagnostic Centers, Others) By Company, By Region, Forecast & Opportunities, 2026”, United States biopsy devices market is expected to witness significant growth for the next five years. Biopsy is a type of procedure which remove the sample of cells or piece of tissue from the patient’s body. The most common types of cancer are breast cancer, lung cancer, colorectal cancer, and stomach cancer. Rising prevalence of cancer is surging the need for more effective, safe, and technologically advanced biopsy procedures. High demand for minimally invasive procedures which are less traumatic, less time-consuming and results in quicker recovery. Increasing life expectancy is leading to rise in old age population and aging is considered one of the major risk factors responsible for development of cancer in the human body which is further bolstering the biopsy devices market.
However, high risk of infections related to biopsy devices and patient safety risks associated with biopsy devices may create hindrance in the biopsy devices market growth.
Browse XX Figures spread through XX Pages and an in-depth TOC on “United States Biopsy Devices Market”.
United States biopsy devices market is segmented into type, technique, product, application, regional distribution, and company. Based on application, market can be further divided into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. The breast biopsy application segment is expected to account for major market share for the forecast period, 2022-2026. Launch of camps and social media campaigns to raise the awareness regarding the breast cancer and its symptoms is driving the biopsy devices market. Increasing prevalence of breast cancer and its adverse effects on the human body is accelerating the market growth. Based on technique, market can be fragmented into ultrasound-guided biopsy, MRI-guided biopsy, stereotactic-guided biopsy, and others. The ultrasound-guided biopsy technique segment is expected to dominate the market for the next five years. The procedure is less invasive than the surgical biopsy and leaves minimal scars on the body. Based on end user, market can be divided into hospitals & clinics, diagnostic centres, and others. The hospitals & clinics segment is anticipated to hold major market share for the forecast period. Strong economic position and well-developed healthcare infrastructure is the major driver for the market growth. Huge expenditure on healthcare facilities and high patient in-flow into the hospitals is contributing significantly to the biopsy devices market growth. Based on type, market can be bifurcated into surgical biopsy and needle biopsy. The needle biopsy segment is expected to hold significant share for the predicted period. Rising demand to obtain soft tissue samples of internal organs such as lungs, kidney and breasts is expected to be a major driver for the forecast period. Increasing need for procuring cell samples is one of the major factors fostering the market growth.
Boston Scientific Corporation, Becton, Dickinson, and Company, Cardinal Health, Inc., Cook Medical, Inc., Argon Medical Devices, Inc., Medtronic USA, Inc., B. Braun Medical Inc., Fujifilm USA, Olympus Corporation of Americas, INRAD, Inc. are the leading players operating in United States biopsy devices market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several biopsy devices manufacturers are coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7531
Customers can also request for 10% free customization on this report.
“Major market players are investing huge amounts for research and development activities such as use of technologically advanced biopsy guidance systems which uses vacuum assisted guns are in high demand in healthcare facilities. These devices are highly efficient and precise and withdraw large volume of sample with minimal number of passes through the skin. Introduction of medical robotic systems offering minimal patient stay in the hospital and aids to increase the number of surgeries performed by the surgeon. Also, the rise in demand for less invasive surgeries and large old age patient pool is anticipated to propel the biopsy devices market growth until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Biopsy Devices Market By Type (Surgical Biopsy v/s Needle Biopsy) By Technique (Ultrasound-guided Biopsy, MRI-guided Biopsy, Stereotactic-guided Biopsy, Others) By Product (Needle-based Biopsy Instruments, Localization Wires, Procedure Trays, Others) By Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others) By End User (Hospitals & Clinics, Diagnostic Centers, Others) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of United States biopsy devices market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of United States biopsy devices market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017